2 unknown, 1 completed, 1 recruiting. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 1, Recruiting 1, Unknown 1 |
Follow Triple antithrombotic therapy: new trials by email Literature Review of Triple antithrombotic therapy trials Research Report on Triple antithrombotic therapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| NOAC Therapy Guided by PARIS Risk Score and D-dimer in Patients With ACS After PCI Aspirin + Clopidogrel + Rivaroxaban, Aspirin + Clopidogrel - Coronary Artery Disease, Percutaneous Coronary Intervention | Phase 4 | Recruiting | China National Center for Cardiovascular Diseases | 3944 | 2023-11-25 | 2026-08-11 |
| Optimal Antithrombotic Therapy for ACS Patients Concomitant With AF and Implanted With New-generation DES (OPTIMA-3, 4) Triple antithrombotic therapy, Dual antithrombotc therapy-1, Dual antithrombotc therapy-2 - Acute Coronary Syndrome (ACS), Non-valvular Atrial Fibrillation (NVAF) | Phase 4 | Unknown | The First Affiliated Hospital with Nanjing Medical University | 3746 | 2018-02-03 | 2023-04-24 |
| Bleeding Events After Triple Antithrombotic Therapy Initiation. Triple antithrombotic therapy - Bleeding | Unknown | Central Hospital, Nancy, France | 200 | 2017-07-15 | 2017-07-11 | |
| Safety of "Ticagrelor+ Warfarin"in Comparison With "Clopidogrel+Aspirin+Warfarin" Ticagrelor+Warfarin, Clopidogrel+Aspirin+Warfarin - Atrial Fibrillation, Coronary Artery Disease | Phase 4 | Completed | Genshan Ma | 296 | 2014-09-19 | 2023-04-14 |
Acute Coronary Syndrome (2) · Coronary Artery Disease (2) · Atrial Fibrillation (1) · Hemorrhage (1)
Central Hospital, Nancy, France (1) · China National Center for Cardiovascular Diseases (1) · Genshan Ma (1) · The First Affiliated Hospital with Nanjing Medical University (1)
China (3)
Chunjian Li, Dr, PhD (1) · Cong Fu, MD. (1) · Genshan Ma, PhD. (1) · Jinqing Yuan, MD (1) · LIjuan Chen, PhD. (1) · Wenbin Lu, MD. (1) · Yu Wang, MD. (1) · Yuyu Yao, Ph.D (1)